AU2001292897A1 - Novel therapy - Google Patents

Novel therapy

Info

Publication number
AU2001292897A1
AU2001292897A1 AU2001292897A AU9289701A AU2001292897A1 AU 2001292897 A1 AU2001292897 A1 AU 2001292897A1 AU 2001292897 A AU2001292897 A AU 2001292897A AU 9289701 A AU9289701 A AU 9289701A AU 2001292897 A1 AU2001292897 A1 AU 2001292897A1
Authority
AU
Australia
Prior art keywords
novel therapy
therapy
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292897A
Inventor
Richard Agustin Bond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Houston
Original Assignee
University of Houston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Houston filed Critical University of Houston
Publication of AU2001292897A1 publication Critical patent/AU2001292897A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
AU2001292897A 2000-09-21 2001-09-20 Novel therapy Abandoned AU2001292897A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23425700P 2000-09-21 2000-09-21
US60234257 2000-09-21
PCT/US2001/029534 WO2002024198A1 (en) 2000-09-21 2001-09-20 Novel therapy

Publications (1)

Publication Number Publication Date
AU2001292897A1 true AU2001292897A1 (en) 2002-04-02

Family

ID=22880602

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292897A Abandoned AU2001292897A1 (en) 2000-09-21 2001-09-20 Novel therapy

Country Status (2)

Country Link
AU (1) AU2001292897A1 (en)
WO (1) WO2002024198A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007527409A (en) 2003-10-09 2007-09-27 インバーセオン、インコーポレイテッド Method for treating airway diseases using β-adrenergic inverse agonists
US7528175B2 (en) 2004-10-08 2009-05-05 Inverseon, Inc. Method of treating airway diseases with beta-adrenergic inverse agonists
DK2665741T3 (en) 2011-01-10 2019-04-29 Invion Inc APPLICATION OF BETA-ADRENERGE INVERSE AGONISTS FOR SMOKE CLEANING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908387A (en) * 1988-06-06 1990-03-13 The Regents Of The University Of California Use of beta2 antagonists in the treatment of inflammatory diseases, in particular, rheumatoid arthritis
US5116867A (en) * 1989-06-30 1992-05-26 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services D-propranolol as a selective adenosine antagonist
JPH10251147A (en) * 1997-03-06 1998-09-22 Akira Matsumori Preventing and/or treating agent for inflammatory disease
US6284800B1 (en) * 1997-03-13 2001-09-04 Baker Norton Pharmaceuticals, Inc. Methods and compositions for treatment of asthma

Also Published As

Publication number Publication date
WO2002024198A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2002222853A1 (en) Therapeutic compounds
AU2002223827A1 (en) Well treatment
AU2001252135A1 (en) Therapeutic agents
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002235175A1 (en) Lometrexol combination therapy
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001258924A1 (en) Microsatellite-aflp
AU2002227925A1 (en) Human beta-defensin-3
AU2002335667A1 (en) Modified reoviral therapy
AU2001281921A1 (en) Bdellosomes
AU2001273903A1 (en) Therapeutic agents
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones
AU2001262711A1 (en) Cytoprotectors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001284173A1 (en) Calycins